Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Abstract A133: CASPER: A Phase Ib trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer

A hallmark of PDAC is its ability to reprogram metabolism. A majority of PDAC tumors (50-80%) express low levels of asparagine synthetase (ASNS) rendering them dependent on extracellular asparagine. L-asparaginase (ASNase) depletes systemic asparagine to restrict tumor cell growth, but clinical trials of ASNase i...

Lyndsey Sandow, Adel Kardosh, Emerson Y. Chen et al. · 0 citations
Open access Sep 2026

IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive tumor microenvironment (TME) and poor prognosis. Although major histocompatibility complex class II (MHC-II) is typically expressed by professional antigen-presenting cells, its regulation and significance in malignant PDAC cells remain un...

Can-Ping Chen, Yi Zhang, Xi Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.